Gastrointestinal Manifestations of Autosomal-Dominant Polycystic Kidney Disease Adam E. Mikolajczyk, Helen S. Te, Arlene B. Chapman Clinical Gastroenterology and Hepatology Volume 15, Issue 1, Pages 17-24 (January 2017) DOI: 10.1016/j.cgh.2016.06.017 Copyright © 2017 AGA Institute Terms and Conditions
Figure 1 The Gigot Criteria for classifying polycystic liver disease. Type I is characterized by a liver that has <10 large (>10 cm) cysts. Type II is characterized by diffuse parenchymal involvement by multiple medium-sized cysts with large areas of noncystic parenchyma. Type III is characterized by large numbers of small and medium-sized cysts spread diffusely throughout the parenchyma with only minimal, normal areas. Clinical Gastroenterology and Hepatology 2017 15, 17-24DOI: (10.1016/j.cgh.2016.06.017) Copyright © 2017 AGA Institute Terms and Conditions
Figure 2 Algorithm for the medical and surgical management of polycystic liver disease, which incorporates the Schnelldorfer classification (types A–D). TACE, transarterial chemotherapy embolization. Clinical Gastroenterology and Hepatology 2017 15, 17-24DOI: (10.1016/j.cgh.2016.06.017) Copyright © 2017 AGA Institute Terms and Conditions